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Abstract Ischemia modified albumin detection has great significance in early
diagnosis and treatment of myocardial ischemia. In this study, anti-IMA was
immobilized on the surface of a glass slide using self-assembled DMOAP and PEI,
the binding of antibody and antigen lead to topology-geomorphologic changes on
the slide surface, which induced 5CB molecules orientation transformation and
modulated light transmittance. Results showed that we can detect concentrations as
low as 50 lg/mL IMA. Moreover, this method can be realized with label-free, easy
operation without dependence on equipment, and can be observed by the naked eye.
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Introduction
Acute coronary syndrome (ACS) is a common disease in the cardiovascular system
with extremely highmortality andmorbidity, so early diagnosis ofACS is important to
improve patients’ prognosis and quality of life [1]. Currently, the laboratory
examination, ECG, and clinical manifestations are the popular methods in ACS early
diagnosis, and are still unsatisfactory [2]. Although necrotic biochemical markers,
such as creatine kinase isoenzyme MB (CK-MB), myoglobin (Myo), and cardiac
troponin (cTn), are regarded as a useful tool for clinical treatment [3], thesemakers are
only released from myocardial cells after irreversible lesions. In addition, cTn can be
detectable in patients about 6 h after heart disease occurs. When they have ischemia
symptoms, the level of cTn is under clinical decision limits such that patients have to
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stay in hospital for repeated tests [4]. The incidence of cardiovascular events may be
further reduced if we can diagnosis myocardial ischemia and plan therapeutic
interventions earlier [5]. Therefore, seeking for a reliable biochemical marker of
myocardial ischemia appears particularly important before cTn is generated.
At present, researchers have aroused interest for a new myocardial ischemia
protein, ischemia modified albumin (IMA), which increases rapidly in 5–10 min
after myocardial ischemia happens, and increases continuously during ischemia [6].
IMA provided an effective basis for detection of the early myocardial ischemia, and
FDA approved IMA as a new clinical diagnosis of myocardial ischemia in 2003 [7].
The albumin cobalt binding test (ACB test) is one of the classical techniques in the
IMA assay, and Bar-Or firstly established the manual spectrophotometric method
[8]. However, there are still shortcomings in this method. For instance, IMA cannot
be detected directly, as it binds with the cobalt ion through measuring the capacity
of blood HSA. More false-positive results by the ACB method can cause
interference with the test; there was no way to detect IMA when the blood albumin
concentration was lower than 34 g/L. DTT, the staining agent of ACB, was not
stable with a low melting point and easily volatilized in the air, which threatened
human health [9]. Another classical method, ELISA, also had disadvantages, for
example, the testing time to determine IMA was longer than 1 h, and the operation
process and procedure is complex in general [10].
A liquid crystal (LC) biosensor, which is also called an electronic eye, has been
regarded as a novel sensor technique [11]. LCmolecules demonstrated the orientation
order on special sensitive membrane surfaces, when specific biological molecules
were bonded on membranes; it disturbed the orderly orientation of LCmolecules, and
caused changes in image color and brightness of the sensor as seen through a polarized
microscopic view. In 1998, Abbott began to apply LCmolecules as a sensing element
for biochemical substance analysis and initially developed the field of the LC
biosensor [12]. After further research, he revealed the self-assembly behavior of
phosphor lipid molecules between the liquid phase and water phase, inducing the
liquid crystalmolecules in a particular orientation. A principle based on characteristics
of the binding reaction between biological molecules that affected LC alignment for
changing the polarization image was proposed. Such liquid crystal biosensors can be
used for detecting cells, proteins, polypeptides, IgGs, and organic phosphorus
[13–15]. Moreover, the LC sensor has a wide range of advantages such as simple
operation, rapid response, high sensitivity, and low cost, which makes it stand out
among other sensors. For these reasons, LC applications have ranged from the initial
detection of organic gases and small molecules to biological macromolecules [16, 17].
Ho and Chen [16] introduced a LC-based biosensor for human serum albumin
detection. IMA was a similar protein, therefore, we came up with the idea. Moreover,
studies on myocardial ischemia with LC biosensors are not available so far.
In this study, a simple IMA determinant method based on the LC biosensor has
been reported. The binding between IMA and anti-IMA changed topological
topography on the surface induced LC from an initial vertical homogeneous
alignment orientation into disorder, and modulated light transmittance. Compared
with other methods, the LC biosensor can be in the ascendancy, because of its
simple operation, excellent selectivity, free labeling, and low cost.




IMA, N,N-dimethyl-N-octadecyl (3-aminopropyl) trimethoxysilyl chloride (DMOAP),
and polyetherimide (PEI) were purchased from Sigma-Aldrich company (St. Louis,
USA). LC 4-cyano-4-pentylbiphenyl (5CB) was obtained from Shijiazhuang Huarui
Technology Co. Ltd (Hebei, China). Anti-IMA was provided by Shanghai Gaochuang
Chemical TechnologyCo., Ltd (Shanghai,China). Glass slideswere purchased from the
Fan Pai company (Haimen, China). Copper grids (200 mesh, 20 lm thick) were
obtained from Beijing tech Mirror Company Limited (Beijing, China). Other reagents
were of analytical grade. Anti-IMA was dissolved in KOAc buffer (10 mmol/L,
PH = 5.6), and IMA in 1 9 PBS buffer (containing 0.01 % Tween-20). All the
solutions were treated with ultrasonic degassing before proceeding any further.
Substrate preparation
Glass slides were cut into 2 cm 9 2 cm size, then cleaned with piranha solution
(containing 70 % H2SO4 and 30 % H2O2, v%) at 80 C for 1 h. After that, the slides
were rinsed with copious amount of deionized water and ethanol, and dried with
nitrogen. The treated glass slides were then immersed in aqueous solution
containing 1 % DMOAP, left to stand for 30 min under room temperature, cleaned
with water, and dried with nitrogen, with oven drying at 110 C for 1 h.
Sequentially, the slides were exposed to an ultraviolet (UV) light for 2 min and air-
dried to reserve. The DMOAP-treated assembly glass slides were immersed in
0.005 % PEI solution for 1 h, followed by large amounts of deionized water and
dried under nitrogen gas. The slides were then kept in a dry and ventilated place
before use.
Immobilization of anti-IMA
Firstly, anti-IMA 1 mg/ml was dissolved in 1 9 PBS buffer (pH = 7.4) and
prepared in different concentrations, then dipped in a small amount of anti-IMA on
to glass slides, reacting at room temperature for 1 h. Then, the slides were washed
with 1 9 PBS buffer solution (pH = 7.4, containing 0.01 % Tween-20) and rinsed
with deionized water, and finally dried with nitrogen.
Detection of IMA
Different concentrations of IMA were dissolved in 1 9 PBS buffer solution with
0.01 % Tween-20 (pH = 7.4) and dipped on the middle of glass slides, then rinsed
with deionized water, and dried with nitrogen. The LC cell was made up of two
glass slides, a piece of 20 lm thick copper grid was placed in the center of the
surface, and 5CB molecules were added on the grid with a pipette. The upper slide
only assembled with DMOAP was covered on the other slides, with four clips that
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fixed four sides. The LC cell was heated in constant thermostats (38 C about 5 min
till the LC was finally filled in its entire cavity and showed isotropic arrangement
(40 C). The LC cell slowly cooled down to room temperature (28 C), then LC
molecules went from the isotropic state into the nematic state, and induced LC
vertically on the self-assembly film.
Results and discussion
Detection principle
The design diagram is provided in Fig. 1. A liquid crystal cell was made up of two
glass slides. DMOAP was fixed on the upper slide, and mixed self-assembled
DMOAP/PEI was immobilized on the bottom slide, which was prepared for binding
anti-IMA. When a LC cell was inserted with 5CB molecules and placed in a
polarized microscope, LC molecules were uniformly placed with a vertical
orientation that light could not filter through the cell, and the optical signal
displayed as a uniform black image. After combining with IMA, the immobilized
molecules were enlarged, and this resulted in undulating topography on the surface.
Since the orientation of the LC was sensitive to surface topography, which
originated from characteristics of birefringence, the LC molecules would be
effectively inducing LC molecules from a uniform vertical position to a horizontal
or inclined orientation. The incident light transmitted through the change of
orientation area, resulting in several bright spots appearing on the black background.
Influence of DMOAP/PEI
The aim of self-assembled DMOAP/PEI was to induce LC molecules perpendicular
to uniform orientation on the treated glass slides and to provide a sufficient number
of amino for anti-IMA settling. So it was well worth noting the effects of the








Glass slide with 
DMOAP
LC
Fig. 1 The principle of LC-based biosensor for IMA detection
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proportion was higher, the number of DMOAP was limited so that it could not
effectively induce LC molecules into vertical orientation, and an obvious brief
regent texture was seen as well. As the DMOAP volume ratio increased, most of the
LC molecules had a vertical orientation, and bright spots gradually became smaller,
while the majority of the image area was black. When the volume ratio further
increased to 3:1, the bright spots completely disappeared and the response signal
showed a uniform dark background. Meanwhile, a cross diffraction could be
observed under conoscopic mode, indicating that LC molecules were in homoge-
neous vertical orientation. The higher proportion of DMOAP/PEI ([3:1), and the
less amount of PEI fixed on the slides was unfavourable for the activation of
aminos. Therefore, the volume ratio of DMOAP/PEI was optimally selected to be
3:1.
Immobilization of anti-IMA
As the orientation of LC molecules was sensitive to the surface topographic change
and anti-IMA was a probe to bind specifically with IMA that directly disturbed the
ordered arrangement of 5CB, so immobilization of antibody was an important issue
in the immunoassay for IMA. We dipped different concentrations of anti-IMA on
DMOAP-coated glass slides and fabricated them into LC cells. Results are
demonstrated in Fig. 3. When the anti-IMA concentration was 100 lg/mL, a large
amount of protein adsorbed on glass slides to disrupt LCs transitions and a bright
spot appeared. This phenomenon indicated that a higher concentration may help to
control the LC order. However, some antibodies attached to the surface because of
physical adsorption; the following washed surfactant solution could be easily
removed. Such a condition will directly affect the binding of antibody and antigen.
Therefore, we washed the glass slides, and the concentrations decreased. The bright
area gradually dimmed down and finally turned into a uniform dark ground. We
obtained the critical concentration with 10 lg/mL.
LOD of IMA
Solutions with different concentrations of IMA were firstly dipped on to the glass
slides fixed with anti-IMA, and then made into LC cells with DMOAP-modified
glass slides, and, lastly, the assembled cells were observed under a polarized light
microscope. Results are shown in Fig. 4. When the IMA concentration increased,
Fig. 2 Optical appearance under a cross polarizer of LC cells with 5CB in different volume ratios of
DMOAP/PEI volume ratio a 1:2, b 1:1, c 2:1, d 3:1, e 5:1
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antigen–antibody interactions were enhanced, which disordered the vertical
orientation of LC molecules and increased birefringence behavior. The bright
region became more obvious in the final image. On the contrary, as the
concentrations reduced, the optical image gradually tended to be black, and there
were only several little bright spots left when the concentration reached 50 lg/mL,
indicating that the concentration of IMA was determined to be as low as 50 lg/mL.
We compared the proposed LC sensor with other present methods used in cardiac
diseases. As demonstrated in Table 1, ACB was an indirect assay with blood
albumin levels no less than 34 lg/mL; a direct method such as ELISA with binding
partners showed excellent LOD with 28.6 lg/mL, and the SPR sensor with AuNPs
could detect 100 ng/L. Until now there has been no other LC biosensor reported
IMA assay, and so we made a new attempt in this field. Meanwhile, with the
variations of light intensity in optical images, the signals can be observed by the
naked eye. The LC sensor has realized on-site and rapid detection, which provides a
simple strategy for the detection of IMA.
Specificity
In order to verify the selectivity of this method, we compared optical signal
responses of HSA and human IgG, which have protein structures similar to the
IMA. The three proteins were made into a LC cell as mentioned; we detected
concentrations of 500, 100, 50, and 10 lg/mL, and we used average grey values to
assess the LC response via optical images. Results are displayed in Fig. 5. In 10 lg/
mL, these three proteins were 16 as a grey value, which showed the dark ground
A B  C    D    E
Before
After
Fig. 3 Polarized images of LC cells fabricated with different concentrations of anti-IMA (lg/mL) a 100,
b 50, c 15, d 10, e 0, before and after washing the glass slides
Fig. 4 Optical appearances under cross polarizer of LC cells with 5CB at different concentrations of
IMA (lg/mL) a 500, b 100, c 50, d 10, e 0
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value. With higher concentration, the average grey value from HSA and human IgG
modified LC cells displayed almost identically at about 20, indicating that most of
the areas were black except for some weak spots. This phenomenon may be caused
by small amounts of HSA and human IgG, which was still not fully estimated. In
contrast, the IMA-treated cell was quite different with obvious color texture (high
grey value), which meant that IMA reacted on the surface causing an optical
response. To sum up, the specificity of antigen antibody binding revealed that the
LC biosensor reached high selectivity for IMA detection.
Conclusions
A new LC biosensor was studied on the basis of IMA antigen–antibody binding,
which induced a LC molecular orientation transformation and resulted in optical
signal changes on a glass surface. The morphology was observed by use of a
polarizing microscope. The proposed sensor combined high specificity of antibody
and sensitive optical signal amplification of LC molecules, presented low LOD,
Table 1 The comparison of the IMA LC biosensor with other methods
Method Detection mode Detection limit (lg/mL) References
ACB Indirect assay [34 (blood albumin) [18]
ELISA Direct assay 28.6 [10]
SPR Direct assay 100 [19]











Fig. 5 Selectivities of LC biosensor to IMA, HSA and human IgG
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high specificity, simple operation, and low cost characteristics, and more impor-
tantly, such a method would be helpful to ACS sufferers.
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